| Technology-Enhanced Executive Functioning Intervention for ADHD (NCT04729439) | Children's National Research Institute | 2021-02-03 |
| INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors (NCT04580485) | Incyte Corporation | 2021-02-03 |
| Maternal Mental Health Trial (NCT04685148) | Vibe G Frøkjær, MD, PhD | 2021-02-03 |
| A Study of TAK-510 in Healthy Adults (NCT04731922) | Takeda | 2021-02-03 |
| A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects (NCT05282914) | Korea United Pharm. Inc. | 2021-02-03 |
| Intermittent Fasting and CLL/SLL (NCT04626843) | Eleah Stringer | 2021-02-03 |
| To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550 (NCT04674748) | Incyte Biosciences Japan GK | 2021-02-03 |
| OH2 Oncolytic Viral Therapy in Pancreatic Cancer (NCT04637698) | Binhui Biopharmaceutical Co., Ltd. | 2021-02-02 |
| to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers (NCT04593511) | Luye Pharma Group Ltd. | 2021-02-02 |
| A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men (NCT04722653) | Novo Nordisk A/S | 2021-02-02 |
| Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer (NCT04612751) | AstraZeneca | 2021-02-02 |
| Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects (NCT04638634) | CSL Behring | 2021-02-02 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Brain Networks Implicated in Lifelong Premature Ejaculation Patients (NCT04850703) | Moises Domingo | 2021-02-02 |
| A First-in-Human Study to Assess the Safety and Tolerability of PDNO (NCT04891354) | Attgeno AB | 2021-02-02 |
| A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects (NCT04705077) | SIMR (Australia) Biotech Pty Ltd. | 2021-02-02 |
| A Study of ICP-192 in Patients With Advanced Solid Tumors (NCT04565275) | Beijing InnoCare Pharma Tech Co., Ltd. | 2021-02-01 |
| Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants (NCT06190678) | Eli Lilly and Company | 2021-02-01 |
| Effects Magnesium Sulfate and Labetalol Infusion on Peripheral Perfusion and Pain in Nasal Surgeries (NCT04688203) | Zagazig University | 2021-02-01 |
| A Phase I, Open-Label, Dose Escalation and Cohort Expansion Study of BS HH 002.SA in Patients With AML and MDS (NCT04743115) | Shanghai Bensen Pharmaceutical Co., Ltd. | 2021-02-01 |
| Surgical Nivolumab And Ipilimumab For Recurrent GBM (NCT04606316) | Patrick Wen, MD | 2021-02-01 |
| To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (NCT03651349) | Everfront Biotech Co., Ltd. | 2021-02-01 |
| Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers (NCT04734275) | AstraZeneca | 2021-02-01 |
| GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight (NCT04779697) | Yale University | 2021-02-01 |
| PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04524195) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-02-01 |
| Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants (NCT04718181) | Hoffmann-La Roche | 2021-02-01 |
| Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (NCT04746963) | AsclepiX Therapeutics, Inc. | 2021-02-01 |
| Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution (NCT04667572) | Cornea Associates of Texas | 2021-02-01 |
| ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion (NCT04744051) | American CryoStem Corporation | 2021-02-01 |
| A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer (NCT04608786) | Lee's Pharmaceutical Limited | 2021-02-01 |
| Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging (NCT04514692) | Stanford University | 2021-02-01 |
| The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT04751071) | Sadat City University | 2021-02-01 |
| Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury (NCT04379011) | University of Minnesota | 2021-02-01 |
| The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients (NCT04757571) | Sadat City University | 2021-02-01 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients (NCT04038619) | M.D. Anderson Cancer Center | 2021-02-01 |
| A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body (NCT04712396) | AstraZeneca | 2021-02-01 |
| Healthy Volunteer Study Comparing Tablet and Capsule Formulations (NCT04001998) | Blade Therapeutics | 2021-02-01 |
| Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers (NCT04849559) | Vanda Pharmaceuticals | 2021-02-01 |
| Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery (NCT05536362) | Egymedicalpedia | 2021-02-01 |
| Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26 (NCT04746638) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2021-02-01 |
| Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae (NCT03792360) | Mayo Clinic | 2021-02-01 |
| [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer (NCT04528199) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-02-01 |
| The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma (NCT04762745) | Sun Yat-sen University | 2021-02-01 |
| VLT-015 in Patients With Schizophrenia (NCT05516121) | CF Pharma, LLC | 2021-02-01 |
| Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis (NCT04685031) | Komar University of Science and Technology | 2021-02-01 |
| Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma (NCT04309552) | Weill Medical College of Cornell University | 2021-02-01 |
| Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia (NCT04687657) | First Affiliated Hospital Xi'an Jiaotong University | 2021-02-01 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood (NCT04716894) | Boehringer Ingelheim | 2021-02-01 |
| Bioavailability Study of 2 Oral Formulations of ALXN1840 (NCT04610580) | Alexion Pharmaceuticals, Inc. | 2021-01-31 |
| Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL (NCT04740203) | Zhejiang University | 2021-01-31 |
| A Single-Dose, Bioequivalence Study of FMXIN001 4 mg Microspheres Powder (NCT04713709) | Nasus Pharma | 2021-01-31 |
| Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. (NCT04587739) | University Hospital, Lille | 2021-01-31 |
| Tariquidar-ondansetron Combination in Neuropathic Pain (NCT04603066) | Washington University School of Medicine | 2021-01-31 |
| LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients (NCT04261387) | Lutris Pharma Ltd. | 2021-01-30 |
| Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions (NCT04729998) | Pharmtechnology LLC | 2021-01-30 |
| A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form (NCT04391868) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2021-01-30 |
| Induced-T Cell Like NK Cells for B Cell Malignancies (NCT04747093) | Nanfang Hospital, Southern Medical University | 2021-01-29 |
| A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects (NCT04798209) | Idorsia Pharmaceuticals Ltd. | 2021-01-29 |
| A Study of JNJ-61393215 in Healthy Japanese Male Participants (NCT04713930) | Janssen Pharmaceutical K.K. | 2021-01-29 |
| A Study of JNJ-40411813 in Healthy Japanese Male Participants (NCT04677530) | Janssen Pharmaceutical K.K. | 2021-01-29 |
| Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue (NCT04484740) | Institut National de la Santé Et de la Recherche Médicale, France | 2021-01-29 |
| Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction (NCT04049539) | Ohio State University Comprehensive Cancer Center | 2021-01-29 |
| An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor (NCT04739111) | Dragonboat Biopharmaceutical Company Limited | 2021-01-29 |
| Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome (NCT04655599) | Arena Pharmaceuticals | 2021-01-29 |
| Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer (NCT04285671) | Jonsson Comprehensive Cancer Center | 2021-01-29 |
| Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers (NCT04748536) | Revolo Biotherapeutics | 2021-01-29 |
| Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea (NCT04530747) | Pennington Biomedical Research Center | 2021-01-28 |
| Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants (NCT04729101) | Phathom Pharmaceuticals, Inc. | 2021-01-28 |
| A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT04632108) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2021-01-28 |
| An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib (NCT04485260) | Kartos Therapeutics, Inc. | 2021-01-28 |
| A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function (NCT04699877) | Astellas Pharma Global Development, Inc. | 2021-01-28 |
| Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands) (NCT04854460) | Genuine Research Center, Egypt | 2021-01-28 |
| A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors (NCT04657068) | Artios Pharma Ltd | 2021-01-27 |
| Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian (NCT04670068) | UNC Lineberger Comprehensive Cancer Center | 2021-01-27 |
| Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy (NCT04340752) | NYU Langone Health | 2021-01-27 |
| Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis (NCT04725136) | Kang Stem Biotech Co., Ltd. | 2021-01-27 |
| A Study of HS-10353 in Chinese Participants. (NCT05195203) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-01-27 |
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation (NCT03608631) | M.D. Anderson Cancer Center | 2021-01-27 |
| Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana (NCT04093076) | Inovio Pharmaceuticals | 2021-01-27 |
| Phase 1 Study to Evaluate Safety and Pharmacokinetics of FZJ-003 in Healthy Volunteers (NCT04715529) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2021-01-27 |
| Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC (NCT05001412) | Zhou Chengzhi | 2021-01-27 |
| BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors (NCT04455620) | BioNTech SE | 2021-01-26 |
| A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors (NCT04699929) | Eucure (Beijing) Biopharma Co., Ltd | 2021-01-26 |
| Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer (NCT04477759) | Medical College of Wisconsin | 2021-01-26 |
| MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction) (NCT04050163) | Honya Medical Inc | 2021-01-26 |
| A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions (NCT04718805) | Janssen Research & Development, LLC | 2021-01-26 |
| Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis (NCT02912897) | Nantes University Hospital | 2021-01-26 |
| Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury (NCT04710550) | Massachusetts General Hospital | 2021-01-25 |
| Pharmacokinetic Study of Vivitrol in Healthy Participants (NCT04716881) | Go Medical Industries Pty Ltd | 2021-01-25 |
| A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer (NCT04672356) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-01-25 |
| BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) (NCT04752826) | BioInvent International AB | 2021-01-25 |
| IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC (NCT04665362) | Liang Peng | 2021-01-25 |
| COVID-19 Study of Safety and Tolerability of Alvelestat (NCT04539795) | University of Alabama at Birmingham | 2021-01-25 |
| Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma (NCT04088188) | Academic and Community Cancer Research United | 2021-01-25 |
| Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies (NCT04640246) | Taiga Biotechnologies, Inc. | 2021-01-25 |
| Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone (NCT04731376) | Emory University | 2021-01-25 |
| Isatuximab in Combination With Novel Agents in RRMM - Master Protocol (NCT04643002) | Sanofi | 2021-01-25 |
| Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis (NCT04943289) | Joanne Kurtzberg, MD | 2021-01-24 |
| An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers (NCT05148754) | Viriom | 2021-01-23 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients (NCT04592315) | Shanxi Kangbao Biological Product Co., Ltd. | 2021-01-23 |